The following is an extract from an email by Stuart Reece to Drug Watch International (DWI)
It seems to me that the main pillars of this argument rest on the following primary evidentiary supports:
- AGEING (spelt “aging” in the USA) is often defined as an accumulation of deleterious changes over time. What is the toxicopathology of cannabis characterized by?? An accumulation of deleterious changes over time – which is obviously the same;
- The multi-system and panorganismal nature of the cannabis related changes is strong clinical evidence that rather than a process limited just to one organ – such as the brain – what we are actually seeing is indicative of a deeper change across all cells, which likely manifests in certain organ specific ways. This is the list of organ damage below.
- A concatenation of age-defining illnesses:
- The arterial toxicity of cannabis is a very big deal because it is one of the major hallmarks of ageing – most people in industrialized nations die from stroke or heart attack, and arterial ageing is the major surrogate for organismal / biological ageing. So arterial ageing – far from being a curiosity in the cannabis literature – assumes massive importance in general medical terms
- The association of cannabis with ten cancers is massive. Cancer is also an age defining disease. So one cannot say that cancer is associated with cannabis and so what – this is a very big deal indeed. Cancer is one of the major age defining diseases
- Immunopathy. By stimulating the immune system cannabis increases one of the major ageing pathways. The pro-inflammatory actions of cannabis are now well documented. In ageing medicine this is described as “inflamm-aging.” It is a major pathway to ageing and age related disease, and is known to be linked with high death rates. Cannabis is usually described as being immunosuppressive. But we are learning that the immune system is a very complex place. It is like a trampoline mat. If it goes down in one place it will go up in another. Hence patients with immune compromising disorders like rheumatoid arthritis and systemic lupus get immune complications and autoimmune diseases – including cancer.
- Negative effect on stem cell division. Obviously we need our stem cells healthy so that we can stay healthy. Cannabis advocates cannot have their cake and eat it too. They propose it as a cancer remedy because it stops cell division. Well if you accept that argument then you must also accept that its effect on cell division is negative which has a catastrophic implication for general stem cell health in all tissue beds
- The effects on children. If children are born with mental compromise, paediatric cancers, and foetal malformations then that is a sign of infantile induction of ageing both by definition – since cancer defines age related disease – and since this is obviously an accumulation of deleterious ages in the paediatric age group.
- Genotoxicity. The association of cannabis with both cancer, congenital malformations, mental retardation in offspring and congenital cancers becomes strong presumptive evidence for genotoxicity. This is one of the best described pathways to cellular and organismal ageing. Congenital cancers (rhabdomyosarcoma, leukaemia and neuroblastoma) are ALWAYS due to genetic defects inherited from parents or earlier generations
- Epigenotoxicity. As you are aware it is now a matter of record that cannabis has now well documented epigenetic changes (Szutorisz 2018; Neuroscience Behav Rev 85: 93). The epigenetic levels is one of the strongest hypothesized levels for ageing. In truth it interacts strongly with the metabolome (since that supplies its substrates) and the genome (since epigenetics seems to often determine sites of DNA cutting and gene splicing both in normal cells and in cancer). The epigenetic signature of cannabis has even been traced through sperm (Lombard). Hence ageing has an epigenetic signature and so too does cannabis. Whilst the two have NOT been formally compared to my knowledge, in view of the above it seems more than likely that significant overlap will be found. Indeed cannabis induced changes in some major epigenetic enzymes, particularly Sirt2 – likely the best age-documented enzyme ever – were documented by Quinn (2008; Neuropsychopharmacology 33:1113). Inheritable epigenetic immunotoxicity was also documented by Lombard C (2011; JPET 339:607)
Source: Email from Stuart Reece to Drug Watch International drug-watch-international@googlegroups.com February 2018